AGP Executive Report
Last update: 6 hours agoLyme Prevention in the Spotlight: Nantucket’s long-running Lyme disease problem is driving a new MIT-linked effort, “Mice Against Ticks,” aiming to disrupt the tick life cycle by targeting the role of white-footed mice. Obesity Drug Updates: Boehringer Ingelheim’s survodutide Phase III results report targeted reductions in visceral and liver fat with limited lean-mass loss, adding momentum to GLP-1/dual-agonist obesity care. Autoimmune + Obesity Heart Outcomes: New research finds GLP-1 therapies are tied to fewer emergency visits and lower rates of serious cardiac events in adults with obesity plus autoimmune disease. Food Assistance Court Fight: A federal judge blocked Trump SNAP funding conditions tied to immigration and LGBTQ-related policies, a win for 20 states and DC that Massachusetts AG Andrea Joy Campbell says protects families from going hungry. Primary Care Access Pressure in Rhode Island: A physician shortage story highlights how practice closures and thin provider supply are leaving residents with long waits and fewer options. Massachusetts Care Delivery Watch: CMS ratings updates flag quality concerns at West Coast-area rehab facilities, underscoring ongoing scrutiny of nursing and rehab outcomes.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.